Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract

Urologia Internationalis

Volumn 62, Issue 1, 1999, Pages 26-30

  Konety, Badrinath R ^a,b   Metro, Michael J ^a   Melham, Mona F ^a   Salup, Raoul R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Bladder cancer, diagnosis; Cytology

Indexed keywords

ARTICLE; BLADDER BIOPSY; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; CYSTOSCOPY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIODIAGNOSIS; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CANCER; URINE CYTOLOGY;

BIOPSY; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; URINARY BLADDER; URINARY BLADDER NEOPLASMS; URINE; UROGRAPHY;

EID: 0032787802     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030350     Document Type: Article

References (19)

1. Umiker W: Accuracy of cytologic diagnosis of cancer of the urinary tract. Acta Cytol 1964;8: 186-193.
2. Zein TA, Milad MF: Urine cytology in bladder tumors. Int Surg 1991;76:52-54.
3. Cummings KB, Barone JG, Ward WS: Diagnosis and staging of bladder cancer. Urol Clin North Am 1992;19:455-465.
4. Koss LG, Deitch D, Ramanathan R, Sherman AB: Diagnostic value of cytology of voided urine. Acta Cytol 1985;29:810-815.
5. Brannan W, Lucas TA, Mitchell WT Jr: Accuracy of cytologic examination of urinary sediment in the detection of urothelial tumors. J Urol 1973;109:483-486.
6. Harving N, Wolf H, Melsen F: Positive urinary cytology after tumor resection: An indicator for concomitant carcinoma in situ. J Urol 1988; 140:495-497.
7. Muller F, Kraft R, Zingg E: Exfoliative cytology after transurethral resection of superficial bladder tumours. Br J Urol 1985;57:530-534.
8. Badalament RA, Gay H, Cibas ES, Herr HW, Whitmore WF Jr, Fair WR, Melamed MR: Monitoring endoscopic treatment of superifical bladder carcinoma by postoperative urinary cytology. J Urol 1987;138:760-762.
9. Fletcher RH, Fletcher SW, Wagner EH: Clinical Epidemiology - The Essentials. Baltimore, Williams & Wilkins, 1988, pp 19-59.
10. Schwalb DM, Herr HW, Fair WR: The management of clinically unconfirmed positive urinary cytology. J Urol 1993;150:1751-1756.
11. Catalona WJ: Urothelial tumors of the urinary tract; in Walsh PC, Retik AB, Stamey TA, Vaughan DE (eds): Campbells Urology, ed 6. Philadelphia, Saunders, 1992, pp 1094-1158.
12. Badalament RA, Hermansen DK, Kimmel M, Gay H, Herr HW, Fair WR, Whitmore WF, Melamed MR: The sensitivity of bladder wash flow cytometry, bladder wash cytology and voided cytology in the detection of bladder carcinoma. Cancer 1987;60:1423-1427.
13. Trott PA, Edwards L: Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer. J Urol 1973:110:664-666.
14. Murphy WM, Crabtree WN, Jukkola AF, Soloway MS: The diagnostic value of urine versus bladder washing in patients with bladder cancer. J Urol 1981;126:320-322.
15. Sheinfeld J, Reuter VE, Melamed MR, et al: Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. J Urol 1990;143:285-288.
16. X) on transitional cell carcinoma of the bladder. Urol Int 1997;58:69-74.
17. Konety B, Getzenberg RH, Bahnson RR: Diagnostic and prognostic markers in bladder cancer. Contemp Urol 1996;8:15-35.
18. Sarosdy MF, deVere White RW, Soloway MS, et al: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 1995;154:379-384.
19. Getzenberg RH, Konety B, Oeler TA, Quigley MM, Hakam A, Becich MJ, Bahnson RR: Bladder cancer associated nuclear matrix proteins. Cancer Res 1996;56:1690-1694.